SEC 13F Intelligence

Cheyne Capital Management (UK) LLP / HRTX

Cheyne Capital Management (UK) LLP’s Heron Therapeutics Inc Position

Does Cheyne Capital Management (UK) LLP own Heron Therapeutics Inc (HRTX)? Not currently — the last reported position was 318.0K shares worth $795,020 in Q4 2022; the fund’s latest 13F (Q4 2023) no longer reports it.

Position Value
$795,020
Q4 2022
Shares
318.0K
% of Portfolio
+1.39%
Quarters Held
1
position exited

Position History HRTX

Reported value by quarter
Q4 ’22: $795,020Q4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022318.0K$795,020+1.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cheyne Capital Management (UK) LLP’s full portfolio or all institutional holders of HRTX.